|
The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- Fusion Antibodies PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic antibodies - Pretax loss narrows to £548,000 in the six months to September from £792,000 the year prior. Revenue drops to £838,000 from £1.2 million, but the bottom line benefits from £370,000 other operating income compared to nil the year before. Basic loss per share is 0.5 pence compared to 0.8p. Cash position is £250,000 at the end of September compared to £400,000 at the end of March, with a further £543,000 owed by existing debtors. Continues to watch costs carefully. ---------- Shires Income PLC - investor with ‘diversified portfolio’ consisting mainly of UK equities - Net asset value per share rises 12% to 295.78 pence at September 30 from 265.23p the year prior. Earnings per share increase to 9.56p from 8.15p. NAV total return for the period was 15.0% compared to a wider market return of 11.6% as measured by the FTSE All-Share Index. The share price total return was 12.7%. ‘It is pleasing that we have seen a five-year share price total return of 73.5%, with some growth in dividends paid to shareholders, as well as more stability in the share price over the last two years, partly achieved by using share buyback powers,’ the company says. An interim dividend of 3.4p per share is declared, up from 3.2p the year before. ‘The board is confident that the company is well placed to continue to deliver its investment objective in terms of both income and capital growth,’ it says. ---------- Prospex Energy PLC - Europe-focused gas and power project investor - Reports £3.8 million of additional investments have been made in the year-to-date. Of this, £2.7 million is funded from internal resources and the balance, from a net equity raise of £1.1 million in the third quarter. Group full-year 2025 share of gross sales on track to surpass 2024, company says. ---------- TT Electronics PLC - Bronschhofen, Switzerland-based firm which develops and manufactures electronic components, devices, and systems - Trading in the four months ended October 25 is broadly flat compared to the first half of 2025. Group revenue is £150.4 million, with all regions performing broadly in line with expectations. Net debt, excluding lease liabilities, is £77 million, up from £73 million at June 30. Reconfirms previous guidance for 2025, which was for adjusted operating profit to be in line with the consensus of £33.7 million. Achieving this outcome will rely on there being no change to the currently anticipated order delivery timelines. Trading continues to be strong in the group’s European businesses; however, TT has yet to see any evidence of a market recovery in EMS or Components. Believes it is difficult to predict how TT will perform in 2026. However, if market activity remains at current levels, underlying trading in 2026 is expected to be broadly in line with 2025. ---------- IntelliAM AI PLC - South Yorkshire, England-based provider of AI-driven software solutions for the manufacturing and engineering sectors - Raises 250,000 via placing at 110 pence per share. The placing was organised by Oberon Capital, in response to interest from a long-term institutional investor. Proceeds will be used to accelerate the delivery of the co-development partnership with a global engineering manufacturer, announced in September. In addition, plans to raise £150,000 via retail offer. ---------- Zambeef Products PLC - cold chain foods and retail business with operations in Zambia, Nigeria and Ghana - Expects Zambian Kwacha basic earnings per share for the financial year ended September to be 26% higher on-year. This is consistent with the trading update in November. Zambeef says the financial performance has been delivered through strong underlying operational performance, volume growth and disciplined cost management, despite facing a challenging economic environment. ---------- Synectics PLC - Sheffield, England-based provider of advanced security and surveillance systems - Signs five-year extension to an existing framework agreement with UK bus operator, Stagecoach. Under the deal, Synectics’ wholly owned systems integration business, Ocular Integration, will continue to supply and install advanced CCTV systems integrated with Synectics’ Cloud Transport Services on Stagecoach’s fleet of new, factory-built buses. Ocular has been working with Stagecoach since 2003. ---------- Ondo InsurTech PLC - London-based claim prevention technology company - Announces that Nationwide has placed a further order for LeakBot devices and services to expand the program into ten additional states. This follows the successful completion of Nationwide’s first two orders, which together deployed LeakBot across 16 states. ---------- Cellbxhealth PLC - Guildford, England-based liquid biopsy company, formerly called Angle PLC - Plans to raise £6.8 million via a placing of up to 493 million shares, a subscription for around 187 million shares and a retail offer - all at 1.0 pence per share. Anticipates that the fundraise shares will represent 68% of the enlarged share capital. Intends to use the net proceeds as follows: £1.9 million for research and development; £1.0 million for sales and marketing; £1.1 million for restructuring and cost optimisation; £200,000 for IT systems; and £1.8 million for operating costs. ‘With the proceeds of the fundraising, the company is well capitalised to drive commercial revenues. Its commercial roadmap is supported by a leaner operating model, strong cost discipline, and targeted investment in research and development for high-value cancer indications,’ it says. ----------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
